Charles Schwab Investment Management Inc Kal Vista Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 113,496 shares of KALV stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,496
Previous 113,124
0.33%
Holding current value
$1.27 Million
Previous $1.31 Million
1.69%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding KALV
# of Institutions
151Shares Held
54.8MCall Options Held
1.07MPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$75.1 Million15.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.96MShares$55.3 Million1.93% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$55.2 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$54.5 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$52.2 Million2.78% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $275M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...